Peter Hou - DV Biomed Independent Director
| 6539 Stock | TWD 46.00 1.00 2.22% |
Insider
Peter Hou is Independent Director of DV Biomed Co since 2020.
| Tenure | 4 years |
| Phone | 886 2 2791 1826 |
| Web | http://www.dvbiomed.com |
DV Biomed Management Efficiency
The company has return on total asset (ROA) of 8.85 % which means that it generated a profit of $8.85 on every $100 spent on assets. This is normal as compared to the sector avarege. Similarly, it shows a return on equity (ROE) of 23.52 %, meaning that it generated $23.52 on every $100 dollars invested by stockholders. DV Biomed's management efficiency ratios could be used to measure how well DV Biomed manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Cangxiao Li | TWOWAY Communications | N/A | |
| Shohei Kanzaki | Sheng Yu Steel | N/A | |
| Mingyuan Zheng | TWOWAY Communications | N/A | |
| TsunHung Wang | Sheng Yu Steel | N/A | |
| Juming Lin | TWOWAY Communications | N/A | |
| You Wu | U Media Communications | N/A | |
| YingHua Ho | Chun Yuan Steel | N/A | |
| MingHsien Chen | Sheng Yu Steel | N/A | |
| Yun Yuan | U Media Communications | N/A | |
| Meipei Cai | TWOWAY Communications | N/A | |
| RongShy Lin | Chunghwa Telecom Co | 56 | |
| WeiMin Song | Chun Yuan Steel | N/A | |
| RuYu He | Tung Ho Steel | N/A | |
| Yi Li | U Media Communications | N/A | |
| ChoFen Tsai | Chunghwa Telecom Co | N/A | |
| YuHsia Hsieh | Chun Yuan Steel | N/A | |
| Bishuang Chen | TWOWAY Communications | N/A | |
| YoungChang Hsieh | Sheng Yu Steel | N/A | |
| Feng Hong | Chunghwa Telecom Co | N/A | |
| MingChi Chiang | Chun Yuan Steel | N/A | |
| TungChin Lin | Sheng Yu Steel | 59 | |
Management Performance
| Return On Equity | 23.52 | |||
| Return On Asset | 8.85 |
DV Biomed Leadership Team
Elected by the shareholders, the DV Biomed's board of directors comprises two types of representatives: DV Biomed inside directors who are chosen from within the company, and outside directors, selected externally and held independent of 6539. The board's role is to monitor DV Biomed's management team and ensure that shareholders' interests are well served. DV Biomed's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, DV Biomed's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Qunzhi Chen, Independent Director | ||
| Peter Hou, Independent Director | ||
| Xiumei Xie, Chief Financial Officer, Head of Finance | ||
| Liqi Zhang, Chairman of the Board, General Manager | ||
| RongChun Lin, Independent Director | ||
| Senxiong Zhang, Independent Director | ||
| Qingjun Huang, Deputy General Manager-Administration Division | ||
| Mingtong Chen, Director | ||
| Jiaqi Zhang, Director | ||
| Mingfeng He, Head of Finance & Accounting | ||
| Yiyun Li, Chief Operating Officer |
6539 Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is DV Biomed a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 23.52 | |||
| Return On Asset | 8.85 | |||
| Profit Margin | 16.64 % | |||
| Operating Margin | 14.88 % | |||
| Current Valuation | 3.68 B | |||
| Shares Outstanding | 59.26 M | |||
| Price To Earning | 13.49 X | |||
| Price To Book | 3.33 X | |||
| Price To Sales | 2.22 X | |||
| Revenue | 1.81 B |
Thematic Opportunities
Explore Investment Opportunities
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in DV Biomed Co. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Complementary Tools for 6539 Stock analysis
When running DV Biomed's price analysis, check to measure DV Biomed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy DV Biomed is operating at the current time. Most of DV Biomed's value examination focuses on studying past and present price action to predict the probability of DV Biomed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move DV Biomed's price. Additionally, you may evaluate how the addition of DV Biomed to your portfolios can decrease your overall portfolio volatility.
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |